Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Hormel Foods to Buy Brakebush Brothers for $1.06 Billion

Hormel Foods to Buy Brakebush Brothers for $1.06 Billion

MT newswireMT newswire2026/09/30 10:51
06:51 AM EDT, 09/30/2026 (MT Newswires) -- Hormel Foods (HRL) signed a definitive deal to acquire Brakebush Brothers, a value-added chicken company, for about $1.06 billion, according to a Wednesday statement. The transaction is in line with Hormel Foods' strategy of investing in growing protein categories, the company said. Brakebush Brothers' acquisition is expected to generate operational synergies and is estimated to be accretive to adjusted earnings per share starting in fiscal 2028, Hormel Foods added. Hormel Foods expects to close the purchase in Q1 of its fiscal 2027 period and said Brakebush Brothers will be housed under its Foodservice segment.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12